<PubmedArticleSet>
    <PubmedArticle>
        <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
            <PMID Version="1">29456534</PMID>
            <DateRevised>
                <Year>2018</Year>
                <Month>11</Month>
                <Day>13</Day>
            </DateRevised>
            <Article PubModel="Electronic-eCollection">
                <Journal>
                    <ISSN IssnType="Print">1664-3224</ISSN>
                    <JournalIssue CitedMedium="Print">
                        <Volume>9</Volume>
                        <PubDate>
                            <Year>2018</Year>
                        </PubDate>
                    </JournalIssue>
                    <Title>Frontiers in immunology</Title>
                    <ISOAbbreviation>Front Immunol</ISOAbbreviation>
                </Journal>
                <ArticleTitle>Critical Role of TGF-β and IL-2 Receptor Signaling in Foxp3 Induction by an Inhibitor of DNA Methylation.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>125</MedlinePgn>
                </Pagination>
                <ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2018.00125</ELocationID>
                <Abstract>
                    <AbstractText>Under physiological conditions, CD4<sup>+</sup> regulatory T (Treg) cells expressing the transcription factor Foxp3 are generated in the thymus [thymus-derived Foxp3<sup>+</sup> Treg (tTregs) cells] and extrathymically at peripheral sites [peripherally induced Foxp3<sup>+</sup> Treg (pTreg) cell], and both developmental subsets play non-redundant roles in maintaining self-tolerance throughout life. In addition, a variety of experimental <i>in vitro</i> and <i>in vivo</i> modalities can extrathymically elicit a Foxp3<sup>+</sup> Treg cell phenotype in peripheral CD4<sup>+</sup>Foxp3<sup>-</sup> T cells, which has attracted much interest as an approach toward cell-based therapy in clinical settings of undesired immune responses. A particularly notable example is the <i>in vitro</i> induction of Foxp3 expression and Treg cell activity (iTreg cells) in initially naive CD4<sup>+</sup>Foxp3<sup>-</sup> T cells through T cell receptor (TCR) and IL-2R ligation, in the presence of exogenous TGF-β. Clinical application of Foxp3<sup>+</sup> iTreg cells has been hampered by the fact that TGF-β-driven Foxp3 induction is not sufficient to fully recapitulate the epigenetic and transcriptional signature of <i>in vivo</i> induced Foxp3<sup>+</sup> tTreg and pTreg cells, which includes the failure to imprint iTreg cells with stable Foxp3 expression. This hurdle can be potentially overcome by pharmacological interference with DNA methyltransferase activity and CpG methylation [e.g., by the cytosine nucleoside analog 5-aza-2'-deoxycytidine (5-aza-dC)] to stabilize TGF-β-induced Foxp3 expression and to promote a Foxp3<sup>+</sup> iTreg cell phenotype even in the absence of added TGF-β. However, the molecular mechanisms of 5-aza-dC-mediated Foxp3<sup>+</sup> iTreg cell generation have remained incompletely understood. Here, we show that in the absence of exogenously added TGF-β and IL-2, efficient 5-aza-dC-mediated Foxp3<sup>+</sup> iTreg cell generation from TCR-stimulated CD4<sup>+</sup>Foxp3<sup>-</sup> T cells is critically dependent on TGF-βR and IL-2R signaling and that this process is driven by TGF-β and IL-2, which could either be FCS derived or produced by T cells on TCR stimulation. Overall, these findings contribute to our understanding of the molecular mechanisms underlying the process of Foxp3 induction and may provide a rational basis for generating phenotypically and functionally stable iTreg cells.</AbstractText>
                </Abstract>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Freudenberg</LastName>
                        <ForeName>Kristin</ForeName>
                        <Initials>K</Initials>
                        <AffiliationInfo>
                            <Affiliation>Molecular and Cellular Immunology/Immune Regulation, DFG-Center for
                                Regenerative Therapies Dresden (CRTD), Center for Molecular and Cellular Bioengineering
                                (CMCB), Technische Universität Dresden, Dresden, Germany.
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Lindner</LastName>
                        <ForeName>Nadja</ForeName>
                        <Initials>N</Initials>
                        <AffiliationInfo>
                            <Affiliation>Molecular and Cellular Immunology/Immune Regulation, DFG-Center for
                                Regenerative Therapies Dresden (CRTD), Center for Molecular and Cellular Bioengineering
                                (CMCB), Technische Universität Dresden, Dresden, Germany.
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Dohnke</LastName>
                        <ForeName>Sebastian</ForeName>
                        <Initials>S</Initials>
                        <AffiliationInfo>
                            <Affiliation>Molecular and Cellular Immunology/Immune Regulation, DFG-Center for
                                Regenerative Therapies Dresden (CRTD), Center for Molecular and Cellular Bioengineering
                                (CMCB), Technische Universität Dresden, Dresden, Germany.
                            </Affiliation>
                        </AffiliationInfo>
                        <AffiliationInfo>
                            <Affiliation>Osteoimmunology, DFG-Center for Regenerative Therapies Dresden (CRTD), Center
                                for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden,
                                Dresden, Germany.
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Garbe</LastName>
                        <ForeName>Annette I</ForeName>
                        <Initials>AI</Initials>
                        <AffiliationInfo>
                            <Affiliation>Osteoimmunology, DFG-Center for Regenerative Therapies Dresden (CRTD), Center
                                for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden,
                                Dresden, Germany.
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Schallenberg</LastName>
                        <ForeName>Sonja</ForeName>
                        <Initials>S</Initials>
                        <AffiliationInfo>
                            <Affiliation>Molecular and Cellular Immunology/Immune Regulation, DFG-Center for
                                Regenerative Therapies Dresden (CRTD), Center for Molecular and Cellular Bioengineering
                                (CMCB), Technische Universität Dresden, Dresden, Germany.
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Kretschmer</LastName>
                        <ForeName>Karsten</ForeName>
                        <Initials>K</Initials>
                        <AffiliationInfo>
                            <Affiliation>Molecular and Cellular Immunology/Immune Regulation, DFG-Center for
                                Regenerative Therapies Dresden (CRTD), Center for Molecular and Cellular Bioengineering
                                (CMCB), Technische Universität Dresden, Dresden, Germany.
                            </Affiliation>
                        </AffiliationInfo>
                        <AffiliationInfo>
                            <Affiliation>Paul Langerhans Institute Dresden (PLID) of the Helmholtz Zentrum München at
                                the University Hospital and Medical Faculty Carl Gustav Carus of TU Dresden, Dresden,
                                Germany.
                            </Affiliation>
                        </AffiliationInfo>
                        <AffiliationInfo>
                            <Affiliation>German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType UI="D016428">Journal Article</PublicationType>
                </PublicationTypeList>
                <ArticleDate DateType="Electronic">
                    <Year>2018</Year>
                    <Month>02</Month>
                    <Day>02</Day>
                </ArticleDate>
            </Article>
            <MedlineJournalInfo>
                <Country>Switzerland</Country>
                <MedlineTA>Front Immunol</MedlineTA>
                <NlmUniqueID>101560960</NlmUniqueID>
                <ISSNLinking>1664-3224</ISSNLinking>
            </MedlineJournalInfo>
            <CommentsCorrectionsList>
                <CommentsCorrections RefType="Cites">
                    <RefSource>Mol Cells. 2016 Dec;39(12 ):888-897</RefSource>
                    <PMID Version="1">27989104</PMID>
                </CommentsCorrections>
                <CommentsCorrections RefType="Cites">
                    <RefSource>J Exp Med. 2007 Jul 9;204(7):1543-51</RefSource>
                    <PMID Version="1">17591856</PMID>
                </CommentsCorrections>
                <CommentsCorrections RefType="Cites">
                    <RefSource>Eur J Immunol. 2014 Dec;44(12):3632-45</RefSource>
                    <PMID Version="1">25159127</PMID>
                </CommentsCorrections>
                <CommentsCorrections RefType="Cites">
                    <RefSource>Immunity. 2012 Nov 16;37(5):785-99</RefSource>
                    <PMID Version="1">23123060</PMID>
                </CommentsCorrections>
                <CommentsCorrections RefType="Cites">
                    <RefSource>Nat Rev Immunol. 2012 Feb 17;12(3):180-90</RefSource>
                    <PMID Version="1">22343569</PMID>
                </CommentsCorrections>
            </CommentsCorrectionsList>
            <KeywordList Owner="NOTNLM">
                <Keyword MajorTopicYN="N">CNS2</Keyword>
                <Keyword MajorTopicYN="N">DNA methylation</Keyword>
                <Keyword MajorTopicYN="N">Foxp3</Keyword>
                <Keyword MajorTopicYN="N">epigenetic regulation</Keyword>
                <Keyword MajorTopicYN="N">iTreg</Keyword>
            </KeywordList>
        </MedlineCitation>
        <PubmedData>
            <History>
                <PubMedPubDate PubStatus="received">
                    <Year>2017</Year>
                    <Month>10</Month>
                    <Day>16</Day>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="accepted">
                    <Year>2018</Year>
                    <Month>01</Month>
                    <Day>16</Day>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="entrez">
                    <Year>2018</Year>
                    <Month>2</Month>
                    <Day>20</Day>
                    <Hour>6</Hour>
                    <Minute>0</Minute>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="pubmed">
                    <Year>2018</Year>
                    <Month>2</Month>
                    <Day>20</Day>
                    <Hour>6</Hour>
                    <Minute>0</Minute>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="medline">
                    <Year>2018</Year>
                    <Month>2</Month>
                    <Day>20</Day>
                    <Hour>6</Hour>
                    <Minute>1</Minute>
                </PubMedPubDate>
            </History>
            <PublicationStatus>epublish</PublicationStatus>
            <ArticleIdList>
                <ArticleId IdType="pubmed">29456534</ArticleId>
                <ArticleId IdType="doi">10.3389/fimmu.2018.00125</ArticleId>
                <ArticleId IdType="pmc">PMC5801288</ArticleId>
            </ArticleIdList>
        </PubmedData>
    </PubmedArticle>
    <PubmedArticle>
        <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
            <PMID Version="1">29736257</PMID>
            <DateRevised>
                <Year>2018</Year>
                <Month>08</Month>
                <Day>15</Day>
            </DateRevised>
            <Article PubModel="Electronic-eCollection">
                <Journal>
                    <ISSN IssnType="Print">2056-5968</ISSN>
                    <JournalIssue CitedMedium="Print">
                        <Volume>3</Volume>
                        <PubDate>
                            <Year>2017</Year>
                        </PubDate>
                    </JournalIssue>
                    <Title>Cell discovery</Title>
                    <ISOAbbreviation>Cell Discov</ISOAbbreviation>
                </Journal>
                <ArticleTitle>Evidence that S6K1, but not 4E-BP1, mediates skeletal muscle pathology associated with loss of A-type lamins.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>17039</MedlinePgn>
                </Pagination>
                <ELocationID EIdType="doi" ValidYN="Y">10.1038/celldisc.2017.39</ELocationID>
                <Abstract>
                    <AbstractText>The mechanistic target of rapamycin (mTOR) signaling pathway plays a central role in aging and a number of different disease states. Rapamycin, which suppresses activity of the mTOR complex 1 (mTORC1), shows preclinical (and sometimes clinical) efficacy in a number of disease models. Among these are <i>Lmna</i><sup>
                        <i>-/-</i>
                    </sup> mice, which serve as a mouse model for dystrophy-associated laminopathies. To confirm that elevated mTORC1 signaling is responsible for the pathology manifested in <i>Lmna</i><sup>
                        <i>-/-</i>
                    </sup> mice and to decipher downstream genetic mechanisms underlying the benefits of rapamycin, we tested in <i>Lmna</i><sup>
                        <i>-/-</i>
                    </sup> mice whether survival could be extended and disease pathology suppressed either by reduced levels of S6K1 or enhanced levels of 4E-BP1, two canonical mTORC1 substrates. Global heterozygosity for <i>S6K1</i> ubiquitously extended lifespan of <i>Lmna</i><sup>
                        <i>-/-</i>
                    </sup> mice (<i>Lmna</i><sup>
                        <i>-/-</i>
                    </sup><i>S6K1</i><sup>
                        <i>+/-</i>
                    </sup> mice). This life extension is due to improving muscle, but not heart or adipose, function, consistent with the observation that genetic ablation of <i>S6K1</i> specifically in muscle tissue also extended survival of <i>Lmna</i><sup>
                        <i>-/-</i>
                    </sup> mice. In contrast, whole-body overexpression of 4E-BP1 shortened the survival of <i>Lmna</i><sup>
                        <i>-/-</i>
                    </sup> mice, likely by accelerating lipolysis. Thus, rapamycin-mediated lifespan extension in <i>Lmna</i><sup>
                        <i>-/-</i>
                    </sup> mice is in part due to the improvement of skeletal muscle function and can be phenocopied by reduced S6K1 activity, but not 4E-BP1 activation.</AbstractText>
                </Abstract>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Liao</LastName>
                        <ForeName>Chen-Yu</ForeName>
                        <Initials>CY</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Anderson</LastName>
                        <ForeName>Sydney S</ForeName>
                        <Initials>SS</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Chicoine</LastName>
                        <ForeName>Nicole H</ForeName>
                        <Initials>NH</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Mayfield</LastName>
                        <ForeName>Jarrott R</ForeName>
                        <Initials>JR</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Garrett</LastName>
                        <ForeName>Brittany J</ForeName>
                        <Initials>BJ</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Kwok</LastName>
                        <ForeName>Charlotte S</ForeName>
                        <Initials>CS</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Academia</LastName>
                        <ForeName>Emmeline C</ForeName>
                        <Initials>EC</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Hsu</LastName>
                        <ForeName>Yueh-Mei</ForeName>
                        <Initials>YM</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Miller</LastName>
                        <ForeName>Delana M</ForeName>
                        <Initials>DM</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Bair</LastName>
                        <ForeName>Amanda M</ForeName>
                        <Initials>AM</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Wilson</LastName>
                        <ForeName>Joy A</ForeName>
                        <Initials>JA</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Tannady</LastName>
                        <ForeName>Gabriella</ForeName>
                        <Initials>G</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Stewart</LastName>
                        <ForeName>Erin M</ForeName>
                        <Initials>EM</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Adamson</LastName>
                        <ForeName>Stuart S</ForeName>
                        <Initials>SS</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Wang</LastName>
                        <ForeName>Junying</ForeName>
                        <Initials>J</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Withers</LastName>
                        <ForeName>Dominic J</ForeName>
                        <Initials>DJ</Initials>
                        <AffiliationInfo>
                            <Affiliation>MRC London Institute of Medical Sciences, London, UK.</Affiliation>
                        </AffiliationInfo>
                        <AffiliationInfo>
                            <Affiliation>Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Kennedy</LastName>
                        <ForeName>Brian K</ForeName>
                        <Initials>BK</Initials>
                        <AffiliationInfo>
                            <Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation>
                        </AffiliationInfo>
                        <AffiliationInfo>
                            <Affiliation>Departments of Biochemistry and Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation>
                        </AffiliationInfo>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <GrantList CompleteYN="Y">
                    <Grant>
                        <Agency>Wellcome Trust</Agency>
                        <Country>United Kingdom</Country>
                    </Grant>
                    <Grant>
                        <GrantID>BB/H020527/2</GrantID>
                        <Agency>Biotechnology and Biological Sciences Research Council</Agency>
                        <Country>United Kingdom</Country>
                    </Grant>
                    <Grant>
                        <GrantID>R01 AG050441</GrantID>
                        <Acronym>AG</Acronym>
                        <Agency>NIA NIH HHS</Agency>
                        <Country>United States</Country>
                    </Grant>
                </GrantList>
                <PublicationTypeList>
                    <PublicationType UI="D016428">Journal Article</PublicationType>
                </PublicationTypeList>
                <ArticleDate DateType="Electronic">
                    <Year>2017</Year>
                    <Month>10</Month>
                    <Day>31</Day>
                </ArticleDate>
            </Article>
            <MedlineJournalInfo>
                <Country>England</Country>
                <MedlineTA>Cell Discov</MedlineTA>
                <NlmUniqueID>101661034</NlmUniqueID>
                <ISSNLinking>2056-5968</ISSNLinking>
            </MedlineJournalInfo>
            <CommentsCorrectionsList>
                <CommentsCorrections RefType="Cites">
                    <RefSource>Hum Mol Genet. 2000 Jan 1;9(1):109-12</RefSource>
                    <PMID Version="1">10587585</PMID>
                </CommentsCorrections>
                <CommentsCorrections RefType="Cites">
                    <RefSource>Biochem Biophys Res Commun. 2002 Mar 1;291(3):522-7</RefSource>
                    <PMID Version="1">11855819</PMID>
                </CommentsCorrections>
                <CommentsCorrections RefType="Cites">
                    <RefSource>Int Rev Cell Mol Biol. 2015;320:41-73</RefSource>
                    <PMID Version="1">26614871</PMID>
                </CommentsCorrections>
                <CommentsCorrections RefType="Cites">
                    <RefSource>Science. 2003 Jun 27;300(5628):2055</RefSource>
                    <PMID Version="1">12702809</PMID>
                </CommentsCorrections>
            </CommentsCorrectionsList>
            <KeywordList Owner="NOTNLM">
                <Keyword MajorTopicYN="N">4E-BP1</Keyword>
                <Keyword MajorTopicYN="N">Lmna−/− mice</Keyword>
                <Keyword MajorTopicYN="N">S6K1</Keyword>
                <Keyword MajorTopicYN="N">lifespan</Keyword>
                <Keyword MajorTopicYN="N">mTORC1</Keyword>
                <Keyword MajorTopicYN="N">muscle</Keyword>
                <Keyword MajorTopicYN="N">rapamycin</Keyword>
            </KeywordList>
            <CoiStatement>The authors declare no conflict of interests.</CoiStatement>
        </MedlineCitation>
        <PubmedData>
            <History>
                <PubMedPubDate PubStatus="received">
                    <Year>2017</Year>
                    <Month>06</Month>
                    <Day>08</Day>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="accepted">
                    <Year>2017</Year>
                    <Month>09</Month>
                    <Day>04</Day>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="entrez">
                    <Year>2018</Year>
                    <Month>5</Month>
                    <Day>9</Day>
                    <Hour>6</Hour>
                    <Minute>0</Minute>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="pubmed">
                    <Year>2018</Year>
                    <Month>5</Month>
                    <Day>8</Day>
                    <Hour>6</Hour>
                    <Minute>0</Minute>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="medline">
                    <Year>2018</Year>
                    <Month>5</Month>
                    <Day>8</Day>
                    <Hour>6</Hour>
                    <Minute>1</Minute>
                </PubMedPubDate>
            </History>
            <PublicationStatus>epublish</PublicationStatus>
            <ArticleIdList>
                <ArticleId IdType="pubmed">29736257</ArticleId>
                <ArticleId IdType="doi">10.1038/celldisc.2017.39</ArticleId>
                <ArticleId IdType="pmc">PMC5931234</ArticleId>
            </ArticleIdList>
        </PubmedData>
    </PubmedArticle>
    <PubmedArticle>
        <MedlineCitation Status="MEDLINE" Owner="NLM">
            <PMID Version="1">20453483</PMID>
            <DateCompleted>
                <Year>2011</Year>
                <Month>08</Month>
                <Day>24</Day>
            </DateCompleted>
            <DateRevised>
                <Year>2015</Year>
                <Month>11</Month>
                <Day>19</Day>
            </DateRevised>
            <Article PubModel="Print-Electronic">
                <Journal>
                    <ISSN IssnType="Electronic">1423-0003</ISSN>
                    <JournalIssue CitedMedium="Internet">
                        <Volume>57</Volume>
                        <Issue>3</Issue>
                        <PubDate>
                            <Year>2011</Year>
                        </PubDate>
                    </JournalIssue>
                    <Title>Gerontology</Title>
                    <ISOAbbreviation>Gerontology</ISOAbbreviation>
                </Journal>
                <ArticleTitle>Coping strategies used by seniors going through the normal aging process: does fear of falling matter?</ArticleTitle>
                <Pagination>
                    <MedlinePgn>228-36</MedlinePgn>
                </Pagination>
                <ELocationID EIdType="doi" ValidYN="Y">10.1159/000314529</ELocationID>
                <Abstract>
                    <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Recent studies show that fear of falling, a frequent fear of community-dwelling seniors, can have a negative impact on their health and quality of life. When fear of falling is intense, it can prompt individuals to limit or avoid certain activities. This activity restriction can lead to premature physical and functional decline and, ultimately, increase the risk for falls. Although activity avoidance/restriction is a common strategy used by seniors to cope with fear of falling, they may use other strategies as well to cope with this fear. However, these other strategies have received little attention to date.</AbstractText>
                    <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed at examining and comparing coping strategies used by seniors with and without fear of falling. It also examined if fear of falling is an independent correlate of the use of coping strategies among seniors.</AbstractText>
                    <AbstractText Label="METHODS" NlmCategory="METHODS">288 seniors aged 65 years or over and going through the normal aging process were assessed during structured home interviews. Fear of falling was assessed through a single question (Are you afraid of falling?) and a 4-category response scale (never, occasionally, often, very often). Coping strategies used by participants were assessed with the Inventory of Coping Strategies Used by the Elderly.</AbstractText>
                    <AbstractText Label="RESULTS" NlmCategory="RESULTS">Findings show that seniors with fear of falling use several coping strategies other than activity avoidance/restriction in their daily functioning. Compared with nonfearful seniors, they tend to use a wider range of coping strategies and use them more frequently. Results also indicate that fear of falling is an independent correlate of diversity and frequency of use of behavioral coping strategies.</AbstractText>
                    <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study suggests that fall prevention practitioners and researchers should document the range and frequency of use of strategies that seniors may employ to cope with fear of falling. These data could help improve interventions and evaluative research in the domain of fall prevention.</AbstractText>
                    <CopyrightInformation>Copyright © 2010 S. Karger AG, Basel.</CopyrightInformation>
                </Abstract>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Filiatrault</LastName>
                        <ForeName>Johanne</ForeName>
                        <Initials>J</Initials>
                        <AffiliationInfo>
                            <Affiliation>School of Rehabilitation, Faculty of Medicine, Université de Montréal,
                                Montreal, Que., Canada. johanne.filiatrault @ umontreal.ca
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Desrosiers</LastName>
                        <ForeName>Johanne</ForeName>
                        <Initials>J</Initials>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <GrantList CompleteYN="Y">
                    <Grant>
                        <GrantID>MOP-68871</GrantID>
                        <Agency>Canadian Institutes of Health Research</Agency>
                        <Country>Canada</Country>
                    </Grant>
                </GrantList>
                <PublicationTypeList>
                    <PublicationType UI="D016428">Journal Article</PublicationType>
                    <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                </PublicationTypeList>
                <ArticleDate DateType="Electronic">
                    <Year>2010</Year>
                    <Month>05</Month>
                    <Day>06</Day>
                </ArticleDate>
            </Article>
            <MedlineJournalInfo>
                <Country>Switzerland</Country>
                <MedlineTA>Gerontology</MedlineTA>
                <NlmUniqueID>7601655</NlmUniqueID>
                <ISSNLinking>0304-324X</ISSNLinking>
            </MedlineJournalInfo>
            <CitationSubset>IM</CitationSubset>
            <MeshHeadingList>
                <MeshHeading>
                    <DescriptorName UI="D000058" MajorTopicYN="Y">Accidental Falls</DescriptorName>
                    <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D000223" MajorTopicYN="Y">Adaptation, Psychological</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName>
                    <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D005239" MajorTopicYN="N">Fear</DescriptorName>
                    <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D011792" MajorTopicYN="N" Type="Geographic">Quebec</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D012111" MajorTopicYN="N">Residence Characteristics</DescriptorName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
                </MeshHeading>
            </MeshHeadingList>
        </MedlineCitation>
        <PubmedData>
            <History>
                <PubMedPubDate PubStatus="received">
                    <Year>2009</Year>
                    <Month>05</Month>
                    <Day>27</Day>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="accepted">
                    <Year>2010</Year>
                    <Month>02</Month>
                    <Day>05</Day>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="entrez">
                    <Year>2010</Year>
                    <Month>5</Month>
                    <Day>11</Day>
                    <Hour>6</Hour>
                    <Minute>0</Minute>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="pubmed">
                    <Year>2010</Year>
                    <Month>5</Month>
                    <Day>11</Day>
                    <Hour>6</Hour>
                    <Minute>0</Minute>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="medline">
                    <Year>2011</Year>
                    <Month>8</Month>
                    <Day>25</Day>
                    <Hour>6</Hour>
                    <Minute>0</Minute>
                </PubMedPubDate>
            </History>
            <PublicationStatus>ppublish</PublicationStatus>
            <ArticleIdList>
                <ArticleId IdType="pubmed">20453483</ArticleId>
                <ArticleId IdType="pii">000314529</ArticleId>
                <ArticleId IdType="doi">10.1159/000314529</ArticleId>
            </ArticleIdList>
        </PubmedData>
    </PubmedArticle>
    <PubmedArticle>
        <MedlineCitation Status="MEDLINE" Owner="NLM">
            <PMID Version="1">27654823</PMID>
            <DateCompleted>
                <Year>2017</Year>
                <Month>03</Month>
                <Day>08</Day>
            </DateCompleted>
            <DateRevised>
                <Year>2017</Year>
                <Month>03</Month>
                <Day>08</Day>
            </DateRevised>
            <Article PubModel="Print-Electronic">
                <Journal>
                    <ISSN IssnType="Electronic">1573-6776</ISSN>
                    <JournalIssue CitedMedium="Internet">
                        <Volume>39</Volume>
                        <Issue>1</Issue>
                        <PubDate>
                            <Year>2017</Year>
                            <Month>Jan</Month>
                        </PubDate>
                    </JournalIssue>
                    <Title>Biotechnology letters</Title>
                    <ISOAbbreviation>Biotechnol. Lett.</ISOAbbreviation>
                </Journal>
                <ArticleTitle>Production of 10S-hydroxy-8(E)-octadecenoic acid from oleic acid by whole recombinant Escherichia coli cells expressing 10S-dioxygenase from Nostoc punctiforme PCC 73102 with the aid of a chaperone.</ArticleTitle>
                <Pagination>
                    <MedlinePgn>133-139</MedlinePgn>
                </Pagination>
                <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10529-016-2225-x</ELocationID>
                <Abstract>
                    <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To increase the production of 10S-hydroxy-8(E)-octadecenoic acid from oleic acid by whole recombinant Escherichia coli cells expressing Nostoc punctiforme 10S-dioxygenase with the aid of a chaperone.</AbstractText>
                    <AbstractText Label="RESULTS" NlmCategory="RESULTS">The optimal conditions for 10S-hydroxy-8(E)-octadecenoic acid production by recombinant cells co-expressing chaperone plasmid were pH 9, 35 °C, 15 % (v/v) dimethyl sulfoxide, 40 g cells l<sup>-1</sup>, and 10 g oleic acid l<sup>-1</sup>. Under these conditions, recombinant cells co-expressing chaperone plasmid produced 7.2 g 10S-hydroxy-8(E)-octadecenoic acid l<sup>-1</sup> within 30 min, with a conversion yield of 72 % (w/w) and a volumetric productivity of 14.4 g l<sup>-1</sup> h<sup>-1</sup>.</AbstractText>
                    <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The activity of recombinant cells expressing 10S-dioxygenase was increased by 200 % with the aid of a chaperone, demonstrating the first biotechnological production of 10S-hydroxy-8(E)-octadecenoic acid using recombinant cells expressing 10S-dioxygenase.</AbstractText>
                </Abstract>
                <AuthorList CompleteYN="Y">
                    <Author ValidYN="Y">
                        <LastName>Kim</LastName>
                        <ForeName>Min-Ji</ForeName>
                        <Initials>MJ</Initials>
                        <AffiliationInfo>
                            <Affiliation>Department of Bioscience and Biotechnology, Konkuk University, Seoul, 05029,
                                Republic of Korea.
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Seo</LastName>
                        <ForeName>Min-Ju</ForeName>
                        <Initials>MJ</Initials>
                        <AffiliationInfo>
                            <Affiliation>Department of Bioscience and Biotechnology, Konkuk University, Seoul, 05029,
                                Republic of Korea.
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Shin</LastName>
                        <ForeName>Kyung-Chul</ForeName>
                        <Initials>KC</Initials>
                        <AffiliationInfo>
                            <Affiliation>Department of Bioscience and Biotechnology, Konkuk University, Seoul, 05029,
                                Republic of Korea.
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                    <Author ValidYN="Y">
                        <LastName>Oh</LastName>
                        <ForeName>Deok-Kun</ForeName>
                        <Initials>DK</Initials>
                        <AffiliationInfo>
                            <Affiliation>Department of Bioscience and Biotechnology, Konkuk University, Seoul, 05029,
                                Republic of Korea. deokkun@konkuk.ac.kr.
                            </Affiliation>
                        </AffiliationInfo>
                    </Author>
                </AuthorList>
                <Language>eng</Language>
                <PublicationTypeList>
                    <PublicationType UI="D016428">Journal Article</PublicationType>
                </PublicationTypeList>
                <ArticleDate DateType="Electronic">
                    <Year>2016</Year>
                    <Month>09</Month>
                    <Day>21</Day>
                </ArticleDate>
            </Article>
            <MedlineJournalInfo>
                <Country>Netherlands</Country>
                <MedlineTA>Biotechnol Lett</MedlineTA>
                <NlmUniqueID>8008051</NlmUniqueID>
                <ISSNLinking>0141-5492</ISSNLinking>
            </MedlineJournalInfo>
            <ChemicalList>
                <Chemical>
                    <RegistryNumber>0</RegistryNumber>
                    <NameOfSubstance UI="D013229">Stearic Acids</NameOfSubstance>
                </Chemical>
                <Chemical>
                    <RegistryNumber>2UMI9U37CP</RegistryNumber>
                    <NameOfSubstance UI="D019301">Oleic Acid</NameOfSubstance>
                </Chemical>
                <Chemical>
                    <RegistryNumber>EC 1.13.11.-</RegistryNumber>
                    <NameOfSubstance UI="D049308">Dioxygenases</NameOfSubstance>
                </Chemical>
            </ChemicalList>
            <CitationSubset>IM</CitationSubset>
            <MeshHeadingList>
                <MeshHeading>
                    <DescriptorName UI="D049308" MajorTopicYN="N">Dioxygenases</DescriptorName>
                    <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                    <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName>
                    <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D046937" MajorTopicYN="N">Nostoc</DescriptorName>
                    <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D019301" MajorTopicYN="N">Oleic Acid</DescriptorName>
                    <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                </MeshHeading>
                <MeshHeading>
                    <DescriptorName UI="D013229" MajorTopicYN="N">Stearic Acids</DescriptorName>
                    <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                </MeshHeading>
            </MeshHeadingList>
            <KeywordList Owner="NOTNLM">
                <Keyword MajorTopicYN="Y">10S-Dioxygenase</Keyword>
                <Keyword MajorTopicYN="Y">10S-Hydroxy-8(E)-octadecenoic acid</Keyword>
                <Keyword MajorTopicYN="Y">Biotransformation</Keyword>
                <Keyword MajorTopicYN="Y">Chaperone</Keyword>
                <Keyword MajorTopicYN="Y">Nostoc punctiforme PCC 73102</Keyword>
                <Keyword MajorTopicYN="Y">Oleic acid</Keyword>
            </KeywordList>
        </MedlineCitation>
        <PubmedData>
            <History>
                <PubMedPubDate PubStatus="received">
                    <Year>2016</Year>
                    <Month>08</Month>
                    <Day>01</Day>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="accepted">
                    <Year>2016</Year>
                    <Month>09</Month>
                    <Day>13</Day>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="pubmed">
                    <Year>2016</Year>
                    <Month>9</Month>
                    <Day>23</Day>
                    <Hour>6</Hour>
                    <Minute>0</Minute>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="medline">
                    <Year>2017</Year>
                    <Month>3</Month>
                    <Day>9</Day>
                    <Hour>6</Hour>
                    <Minute>0</Minute>
                </PubMedPubDate>
                <PubMedPubDate PubStatus="entrez">
                    <Year>2016</Year>
                    <Month>9</Month>
                    <Day>23</Day>
                    <Hour>6</Hour>
                    <Minute>0</Minute>
                </PubMedPubDate>
            </History>
            <PublicationStatus>ppublish</PublicationStatus>
            <ArticleIdList>
                <ArticleId IdType="pubmed">27654823</ArticleId>
                <ArticleId IdType="doi">10.1007/s10529-016-2225-x</ArticleId>
                <ArticleId IdType="pii">10.1007/s10529-016-2225-x</ArticleId>
            </ArticleIdList>
        </PubmedData>
    </PubmedArticle>
</PubmedArticleSet>